Lupin Limited has informed the Exchange regarding a press release dated November 10, 2023, titled "Lupin and Amman Pharma Sign Exclusive Licensing and Supply Agreement forRanibizumab Biosimilar.".
Lupin Limited has informed the Exchange regarding a press release dated November 10, 2023, titled "Lupin and Amman Pharma Sign Exclusive Licensing and Supply Agreement forRanibizumab Biosimilar.".